We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Alexion’s Soliris Gains Approval to Treat Blood Disorder in Japan
Alexion’s Soliris Gains Approval to Treat Blood Disorder in Japan
April 16, 2010
Japan has approved Alexion Pharmaceutical’s Soliris, the nation’s first drug for a very rare blood disorder, paroxysmal nocturnal hemoglobinuria
(PNH).